Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …

Tumor relapse and metastasis are the primary causes of poor survival rates in patients with
advanced cancer despite successful resection or chemotherapeutic treatment. A primary …

Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed
exome sequencing and copy number analysis to define genomic aberrations in a …

Background This position statement was developed to expedite a consensus on definition
and treatment for borderline resectable pancreatic ductal adenocarcinoma (BRPC) that …

Objective: To assess the relevance of resection margin status for survival outcome after
resection and adjuvant therapy for pancreatic cancer. Background: The definitions for R0 …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and
estimated to become the second leading cause of cancer-related deaths by 2030. Although …

Background The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is
poor and selection of patients for surgery is challenging. This study examined the impact of a …

Methods: Analyses were carried out to assess the association between clinical
characteristics and margin involvement as well as the effects of individual margin …

Objective: Patients who undergo an R0 resection of their pancreatic ductal adenocarcinoma
(PDAC) have an improved survival compared with patients who undergo an R1 resection. It …

Objective: The aim of this study was to decipher the true importance of R0 versus R1
resection for survival in pancreatic ductal adenocarcinoma (PDAC). Summary of …